Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pulmonary Tuberculosis V

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...

Pulmonary Tuberculosis I

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...

Pulmonary Tuberculosis IV

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...

Clinical Significance of Antibiotic Resistance

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...

Pneumonia IV: Management

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:

Mechanism of Antibiotic Resistance in MRSA

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

First report of multidrug-resistant <i>M. tuberculosis</i> Beijing strain isolated from the indigenous population in Tunisia.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2025

Same author

2022 TUNISIAN NATIONAL CONGRESS OF MEDICINE ABSTRACTS.

La Tunisie medicale·2023

Same author

[Diagnostic and therapeutic management of operable bronchopulmonary carcinoid tumours].

Revue des maladies respiratoires·2021

Same author

[Phenotypic and molecular detection of carbapenemase-producing Klebsiella pneumoniae strains].

Medecine et maladies infectieuses·2018

Same author

[Clinical and pathological profile of the pleural malignant mesothelioma: A retrospective study about 30 cases].

Revue de pneumologie clinique·2018

Same author

Genetic diversity of Streptococcus pneumoniae in Tunisia.

International journal of antimicrobial agents·2018

Search research articles

Related Experiment Video

Updated: Apr 25, 2026

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

[Management of multidrug-resistant tuberculosis].

F Tritar¹, H Daghfous¹, S Ben Saad¹

¹Service de pneumologie, hôpital A.-Mami, Ariana, 2080 Tunis, Tunisie.

Revue De Pneumologie Clinique

|August 26, 2014

Summary

Multidrug-resistant tuberculosis (MDR-TB) poses a significant global health challenge due to drug resistance. Treatment is lengthy and complex, with cure rates lower than drug-susceptible TB.

Keywords:

MDR-TB Multidrug-resistant tuberculosis Traitement Treatment Tuberculose Tuberculose multirésistante Tuberculosis XDR-TB XDR–TB

More Related Videos

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

Matrix-based DNA Extraction for Targeted Next-Generation Sequencing on Decontaminated Sputum Samples

Matrix-based DNA Extraction for Targeted Next-Generation Sequencing on Decontaminated Sputum Samples

Published on: June 6, 2025

Related Experiment Videos

Last Updated: Apr 25, 2026

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis

Published on: April 5, 2017

Matrix-based DNA Extraction for Targeted Next-Generation Sequencing on Decontaminated Sputum Samples

Matrix-based DNA Extraction for Targeted Next-Generation Sequencing on Decontaminated Sputum Samples

Published on: June 6, 2025

Area of Science:

Microbiology
Public Health
Infectious Diseases

Context:

Drug-resistant tuberculosis (TB) is a growing global health crisis.
Multidrug-resistant TB (MDR-TB) is caused by resistance to isoniazid and rifampicin.
Poor patient adherence is a primary driver of MDR-TB emergence.

Purpose:

To summarize the challenges and current approaches in managing multidrug-resistant tuberculosis.
To highlight the complexities of MDR-TB diagnosis and treatment.
To review the outcomes and mortality associated with MDR-TB.

Summary:

Rapid diagnostic techniques improve early MDR-TB treatment initiation.
MDR-TB treatment involves an 8-month intensive phase with 5 drugs (including injectable and fluoroquinolone) and a prolonged maintenance phase.
Surgery may be considered for localized lesions in patients with adequate cardiorespiratory function.

Impact:

MDR-TB treatment success rates are lower (60-75%) compared to drug-susceptible TB.
Extensively drug-resistant TB (XDR-TB) has even poorer outcomes (30-40% cure rate).
High mortality rates (20-40%, up to 70-90% with HIV co-infection) underscore the severity of MDR-TB.